Laidlaw started coverage on shares of BiomX (NYSEMKT:PHGE – Free Report) in a report released on Tuesday, Benzinga reports. The brokerage issued a buy rating and a $2.50 price objective on the stock. Separately, HC Wainwright reaffirmed a buy rating and set a $2.00 price target on shares of BiomX in a report on Tuesday, […]
BiomX to Present Phase 1b/2a Clinical Trial Data for BX004 at the 47th European Cystic Fibrosis Conference and at ASM Microbe 2024
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.
BiomX Inc Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
BiomX Faces NYSE Delisting Over Equity Deficiency
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.
8Vc Gp I LLC acquired a new position in BiomX Inc. (NYSEAMERICAN:PHGE – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 1,086,191 shares of the company’s stock, valued at approximately $304,000. BiomX comprises about 0.3% of 8Vc […]